BRIEF-Arena Pharmaceuticals reports Q3 loss per share $0.86
November 07, 2017 at 16:04 PM EST
* Arena Pharmaceuticals provides corporate update and reports third quarter 2017 financial results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|